A new analysis of global pharmacovigilance data indicates that while reports of psychiatric distress are common among users ...

The Food and Drug Administration (FDA) declined on Friday to approve MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD). The agency has asked Lykos Therapeutics, ...

MDMA (3,4-methylenedioxymethamphetamine), known colloquially as Molly and Ecstasy, is a synthetic drug with effects similar to stimulants like methamphetamine. It was first synthesized in 1912 by ...

Earlier this month, the Food and Drug Administration declined to approve MDMA-assisted therapy for PTSD. Concerns over the clinical research and questions about whether the benefits outweighed the ...

Hopefully the additional study will also remove the cloud that now sits over Lykos and MDMA as a consequence of the problems and limitations of the Lykos phase 3 program. The bad news about the ...

Learn about the drug that may have taken two lives at a music festival. Sept. 3, 2013— -- If you listen to electronic music, you’re probably familiar with molly. Molly is basically the same as ...

The high incidence of acute hyponatremia after the administration of a single dose of 3,4-methylenedioxymethamphetamine (MDMA), also known as ecstasy, in healthy individuals may be mediated by ...

Successful and viable medical treatments rest on three fundamental pillars of healthcare – safety, efficacy and accessibility. Post-traumatic stress disorder (PTSD) has become a critical area of need ...

Vagus-dependent gut–brain signaling inMDMA-induced stress resilience. MDMA elevates central 5-HT and stimulates peripheral release of 5-HT from enterochromaffin cells, alongside oxytocin from ...

A San Francisco-based biotech company, backed by OpenAI’s Sam Altman, has won government approval to begin clinical trials of a new “safer MDMA”. The company, Arcadia Medicine, which is developing ...